KMI
55
-4
NWL
32
4
AEE
46
11
AEP
56
-2
FCX
47
-9
T
45
3
WU
24
-6
SJM
29
-2
CMA
39
3
CINF
48
-2
AMP
73
-2
DE
29
-3
ADBE
66
4
FIS
50
-3
WEC
45
9
VRSK
89
2
GPC
35
-9
GOOGL
67
3
AAPL
56
-3
BSX
70
2
KMI
55
-4
NWL
32
4
AEE
46
11
AEP
56
-2
FCX
47
-9
T
45
3
WU
24
-6
SJM
29
-2
CMA
39
3
CINF
48
-2
AMP
73
-2
DE
29
-3
ADBE
66
4
FIS
50
-3
WEC
45
9
VRSK
89
2
GPC
35
-9
GOOGL
67
3
AAPL
56
-3
BSX
70
2
Financhill
Back

Leidos Holdings Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
59

LDOS
Leidos Holdings

Last Price:
146.53
Seasonality Move:
-0.86%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Buy
59
Leidos Holdings (LDOS) is a Buy

Is Leidos Holdings a Buy, Sell or Hold?

  • The current Leidos Holdings [LDOS] share price is $146.57. The Score for LDOS is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • LDOS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LDOS Stock Price Chart

What is Leidos Holdings's stock price today?

  • The Leidos Holdings share price today is $146.57
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LDOS is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

LDOS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.65 Buy
Relative Strength Index (14 RSI): 59.27 Buy
Chaikin Money Flow: 1753331 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (144.05 - 148.63) Buy
Bollinger Bands (100): (121.34 - 143.8) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

LDOS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 144.57 Buy
20-day SMA: 145.63 Buy
50-day SMA: 140.82 Buy
200-day SMA: 117.23 Buy
8-day EMA: 145.08 Buy
20-day EMA: 144.92 Buy
50-day EMA: 141.04 Buy
200-day EMA: 122.33 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Leidos Holdings Earnings Growth & LDOS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.15 per share, an increase this year of $1.76 per share, and an increase next year of $0.45 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Leidos Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):